AGIO
Agios Pharmaceuticals, Inc.$24.77+0.34 (+1.41%)Prev Close$24.43·MCap$1.54B·P/E—·Vol511.3K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
34
$5.73M
◆
Net Activity
Net Seller
$5.73M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Agios Pharmaceuticals, Inc. (AGIO) has been exclusively selling, with 0 insider purchases totaling $0.00 and 34 insider sales totaling $5.73M. The most recent insider transaction was by Burns James William (officer: Chief Legal Officer), who sold $113.8K worth of shares on Apr 6, 2026. Agios Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.54B.
AGIO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Burns James William | officer: Chief Legal Officer | Sell | 3,280 | $34.71 | $113.8K | 49,306 |
| Apr 6, 2026 | Gheuens Sarah | officer: Chief Medical Officer | Sell | 2,940 | $34.71 | $102.0K | 80,277 |
| Apr 6, 2026 | Goff Brian | director, officer: Chief Executive Officer | Sell | 19,068 | $34.71 | $661.9K | 184,508 |
| Apr 6, 2026 | Jones Cecilia | officer: Chief Financial Officer | Sell | 3,141 | $34.71 | $109.0K | 54,998 |
| Apr 6, 2026 | Milanova Tsveta | officer: Chief Commercial Officer | Sell | 3,262 | $34.71 | $113.2K | 46,829 |
| Apr 6, 2026 | Viswanadhan Krishnan | officer: Chief Corp Dev & Strategy | Sell | 2,959 | $34.71 | $102.7K | 10,282 |
| Mar 9, 2026 | Viswanadhan Krishnan | officer: Chief Corp Dev & Strategy | Sell | 2,959 | $27.80 | $82.3K | 5,141-37% |
| Mar 3, 2026 | Burns James William | officer: Chief Legal Officer | Sell | 4,031 | $28.96 | $116.7K | 44,086 |
| Mar 3, 2026 | Gheuens Sarah | officer: Chief Medical Officer | Sell | 2,868 | $28.96 | $83.1K | 71,593 |
| Mar 3, 2026 | Goff Brian | director, officer: Chief Executive Officer | Sell | 18,055 | $28.96 | $522.9K | 164,548 |
| Mar 3, 2026 | Jones Cecilia | officer: Chief Financial Officer | Sell | 5,035 | $28.96 | $145.8K | 49,328 |
| Mar 3, 2026 | Milanova Tsveta | officer: Chief Commercial Officer | Sell | 2,868 | $28.96 | $83.1K | 41,591 |
| Mar 3, 2026 | Washburn Theodore James Jr. | officer: Principal Accounting Officer | Sell | 2,223 | $28.96 | $64.4K | 6,140-27% |
| Jan 5, 2026 | Milanova Tsveta | Chief Commercial Officer | Sell | 2,872 | $27.02 | $77.6K | 0 |
| Dec 30, 2025 | Burns James William | Chief Legal Officer | Sell | 2,932 | $27.09 | $79.4K | 0 |
| Dec 30, 2025 | Goff Brian | Chief Executive Officer | Sell | 18,703 | $27.09 | $506.7K | 0 |
| Nov 12, 2025 | Scadden David | Director | Sell | 200 | $43.84 | $8.8K | 0 |
| Nov 11, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 2,454 | $43.78 | $107.4K | 0 |
| Oct 30, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 200 | $43.81 | $8.8K | 0 |
| Oct 27, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 3,302 | $43.92 | $145.0K | 0 |
| Oct 8, 2025 | Scadden David | Director | Sell | 200 | $41.00 | $8.2K | 0 |
| Sep 30, 2025 | Scadden David | Director | Sell | 200 | $40.00 | $8.0K | 0 |
| Sep 26, 2025 | Jones Cecilia | Chief Financial Officer | Sell | 3,651 | $36.77 | $134.2K | 0 |
| Sep 5, 2025 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 8,546 | $36.87 | $315.1K | 0 |
| Aug 27, 2025 | Scadden David | Director | Sell | 200 | $40.00 | $8.0K | 0 |
| Aug 8, 2025 | Goff Brian | Chief Executive Officer | Sell | 11,085 | $36.67 | $406.5K | 0 |
| Jul 10, 2025 | Scadden David | Director | Sell | 1,400 | $40.00 | $56.0K | 0 |
| Jul 9, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 11,914 | $37.99 | $452.6K | 0 |
| Jul 1, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 4,091 | $34.17 | $139.8K | 0 |
| Jun 24, 2025 | Burns James William | Chief Legal Officer | Sell | 2,799 | $33.54 | $93.9K | 0 |
| Jun 24, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 2,909 | $33.54 | $97.6K | 0 |
| Jun 24, 2025 | Goff Brian | Chief Executive Officer | Sell | 18,700 | $33.54 | $627.2K | 0 |
| Jun 24, 2025 | Jones Cecilia | Chief Financial Officer | Sell | 1,780 | $33.54 | $59.7K | 0 |
| Jun 24, 2025 | Milanova Tsveta | Chief Commercial Officer | Sell | 2,770 | $33.54 | $92.9K | 0 |
| Apr 8, 2025 | FOUSE JACQUALYN A | Director | Sell | 7,497 | $25.90 | $194.2K | 0 |
| Mar 1, 2025 | Burns James William | Chief Legal Officer | Sell | 4,005 | $35.54 | $142.3K | 0 |
| Mar 1, 2025 | Goff Brian | Chief Executive Officer | Sell | 12,947 | $35.54 | $460.1K | 0 |
| Mar 1, 2025 | Jones Cecilia | Chief Financial Officer | Sell | 594 | $35.54 | $21.1K | 0 |
| Mar 1, 2025 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 1,655 | $35.54 | $58.8K | 0 |
| Feb 1, 2025 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 2,272 | $34.39 | $78.1K | 0 |
| Jan 3, 2025 | Milanova Tsveta | Chief Commercial Officer | Sell | 2,804 | $32.18 | $90.2K | 0 |
| Dec 11, 2024 | Scadden David | Director | Sell | 200 | $46.28 | $9.3K | 0 |
| Nov 8, 2024 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 772 | $56.09 | $43.3K | 0 |
| Nov 7, 2024 | Ballal Rahul D. | Director | Sell | 20,000 | $55.86 | $1.12M | 0 |
| Nov 7, 2024 | Burns James William | Chief Legal Officer | Sell | 21,752 | $52.21 | $1.14M | 0 |
| Sep 26, 2024 | Jones Cecilia | Chief Financial Officer | Sell | 2,542 | $49.03 | $124.6K | 0 |
| Aug 8, 2024 | Goff Brian | Chief Executive Officer | Sell | 11,091 | $42.75 | $474.1K | 0 |
| Jul 1, 2024 | Gheuens Sarah | Chief Medical Officer | Sell | 3,705 | $43.85 | $162.5K | 0 |
| Jun 5, 2024 | Goff Brian | Chief Executive Officer | Sell | 12,115 | $48.84 | $591.7K | 0 |
| Jun 3, 2024 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 1,362 | $44.39 | $60.5K | 0 |
Showing 1–50 of 142
1 / 3
AGIO Insider Buying Activity
The following table shows recent insider purchases of Agios Pharmaceuticals, Inc. (AGIO) stock reported via SEC Form 4 filings.
No insider buying activity found for AGIO in the last 12 months.
AGIO Insider Selling Activity
The following table shows recent insider sales of Agios Pharmaceuticals, Inc. (AGIO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Burns James William | officer: Chief Legal Officer | Sell | 3,280 | $34.71 | $113.8K | 49,306 |
| Apr 6, 2026 | Gheuens Sarah | officer: Chief Medical Officer | Sell | 2,940 | $34.71 | $102.0K | 80,277 |
| Apr 6, 2026 | Goff Brian | director, officer: Chief Executive Officer | Sell | 19,068 | $34.71 | $661.9K | 184,508 |
| Apr 6, 2026 | Jones Cecilia | officer: Chief Financial Officer | Sell | 3,141 | $34.71 | $109.0K | 54,998 |
| Apr 6, 2026 | Milanova Tsveta | officer: Chief Commercial Officer | Sell | 3,262 | $34.71 | $113.2K | 46,829 |
| Apr 6, 2026 | Viswanadhan Krishnan | officer: Chief Corp Dev & Strategy | Sell | 2,959 | $34.71 | $102.7K | 10,282 |
| Mar 9, 2026 | Viswanadhan Krishnan | officer: Chief Corp Dev & Strategy | Sell | 2,959 | $27.80 | $82.3K | 5,141-37% |
| Mar 3, 2026 | Burns James William | officer: Chief Legal Officer | Sell | 4,031 | $28.96 | $116.7K | 44,086 |
| Mar 3, 2026 | Gheuens Sarah | officer: Chief Medical Officer | Sell | 2,868 | $28.96 | $83.1K | 71,593 |
| Mar 3, 2026 | Goff Brian | director, officer: Chief Executive Officer | Sell | 18,055 | $28.96 | $522.9K | 164,548 |
| Mar 3, 2026 | Jones Cecilia | officer: Chief Financial Officer | Sell | 5,035 | $28.96 | $145.8K | 49,328 |
| Mar 3, 2026 | Milanova Tsveta | officer: Chief Commercial Officer | Sell | 2,868 | $28.96 | $83.1K | 41,591 |
| Mar 3, 2026 | Washburn Theodore James Jr. | officer: Principal Accounting Officer | Sell | 2,223 | $28.96 | $64.4K | 6,140-27% |
| Jan 5, 2026 | Milanova Tsveta | Chief Commercial Officer | Sell | 2,872 | $27.02 | $77.6K | 0 |
| Dec 30, 2025 | Burns James William | Chief Legal Officer | Sell | 2,932 | $27.09 | $79.4K | 0 |
| Dec 30, 2025 | Goff Brian | Chief Executive Officer | Sell | 18,703 | $27.09 | $506.7K | 0 |
| Nov 12, 2025 | Scadden David | Director | Sell | 200 | $43.84 | $8.8K | 0 |
| Nov 11, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 2,454 | $43.78 | $107.4K | 0 |
| Oct 30, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 200 | $43.81 | $8.8K | 0 |
| Oct 27, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 3,302 | $43.92 | $145.0K | 0 |
| Oct 8, 2025 | Scadden David | Director | Sell | 200 | $41.00 | $8.2K | 0 |
| Sep 30, 2025 | Scadden David | Director | Sell | 200 | $40.00 | $8.0K | 0 |
| Sep 26, 2025 | Jones Cecilia | Chief Financial Officer | Sell | 3,651 | $36.77 | $134.2K | 0 |
| Sep 5, 2025 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 8,546 | $36.87 | $315.1K | 0 |
| Aug 27, 2025 | Scadden David | Director | Sell | 200 | $40.00 | $8.0K | 0 |
| Aug 8, 2025 | Goff Brian | Chief Executive Officer | Sell | 11,085 | $36.67 | $406.5K | 0 |
| Jul 10, 2025 | Scadden David | Director | Sell | 1,400 | $40.00 | $56.0K | 0 |
| Jul 9, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 11,914 | $37.99 | $452.6K | 0 |
| Jul 1, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 4,091 | $34.17 | $139.8K | 0 |
| Jun 24, 2025 | Burns James William | Chief Legal Officer | Sell | 2,799 | $33.54 | $93.9K | 0 |
| Jun 24, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 2,909 | $33.54 | $97.6K | 0 |
| Jun 24, 2025 | Goff Brian | Chief Executive Officer | Sell | 18,700 | $33.54 | $627.2K | 0 |
| Jun 24, 2025 | Jones Cecilia | Chief Financial Officer | Sell | 1,780 | $33.54 | $59.7K | 0 |
| Jun 24, 2025 | Milanova Tsveta | Chief Commercial Officer | Sell | 2,770 | $33.54 | $92.9K | 0 |
| Apr 8, 2025 | FOUSE JACQUALYN A | Director | Sell | 7,497 | $25.90 | $194.2K | 0 |
| Mar 1, 2025 | Burns James William | Chief Legal Officer | Sell | 4,005 | $35.54 | $142.3K | 0 |
| Mar 1, 2025 | Goff Brian | Chief Executive Officer | Sell | 12,947 | $35.54 | $460.1K | 0 |
| Mar 1, 2025 | Jones Cecilia | Chief Financial Officer | Sell | 594 | $35.54 | $21.1K | 0 |
| Mar 1, 2025 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 1,655 | $35.54 | $58.8K | 0 |
| Feb 1, 2025 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 2,272 | $34.39 | $78.1K | 0 |
| Jan 3, 2025 | Milanova Tsveta | Chief Commercial Officer | Sell | 2,804 | $32.18 | $90.2K | 0 |
| Dec 11, 2024 | Scadden David | Director | Sell | 200 | $46.28 | $9.3K | 0 |
| Nov 8, 2024 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 772 | $56.09 | $43.3K | 0 |
| Nov 7, 2024 | Ballal Rahul D. | Director | Sell | 20,000 | $55.86 | $1.12M | 0 |
| Nov 7, 2024 | Burns James William | Chief Legal Officer | Sell | 21,752 | $52.21 | $1.14M | 0 |
| Sep 26, 2024 | Jones Cecilia | Chief Financial Officer | Sell | 2,542 | $49.03 | $124.6K | 0 |
| Aug 8, 2024 | Goff Brian | Chief Executive Officer | Sell | 11,091 | $42.75 | $474.1K | 0 |
| Jul 1, 2024 | Gheuens Sarah | Chief Medical Officer | Sell | 3,705 | $43.85 | $162.5K | 0 |
| Jun 5, 2024 | Goff Brian | Chief Executive Officer | Sell | 12,115 | $48.84 | $591.7K | 0 |
| Jun 3, 2024 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 1,362 | $44.39 | $60.5K | 0 |
AGIO Insiders
Similar Stocks to AGIO
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B